Newly diagnosed type 2 diabetic patients with nonalcoholic fatty liver disease prevalence and risk factors.doc
- 1、本文档共8页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Newly diagnosed type 2 diabetic patients with nonalcoholic fatty liver disease prevalence and risk factors
PAGE \* MERGEFORMAT 8
Newly diagnosed type 2 diabetic patients with nonalcoholic fatty liver disease prevalence and risk factors
Of: Ye Su Pan Hailin Huang Yuan Li Yingrong
[Keywords:] Type 2 diabetes; non-alcoholic fatty liver; waist; triglyceride; insulin resistance
Non-alcoholic fatty liver (NAFLD) is fatty degeneration of liver cells. Characterized by abnormal glucose and lipid metabolism in type 2 diabetes (T2DM) patients the prevalence of NAFLD how? And gender, old age and the incidence among non-elderly Are there differences? NAFLD major risk factor? are to be explored. This paper analyzes the 263 cases of newly diagnosed patients with T2DM risk factors associated with NAFLD.
1 Subjects and methods
1.1 Object June 2005 to April 2009 in our hospital inpatient metabolic Diabetes Center of 263 patients with newly diagnosed T2DM patients, are in line with WHO (1999) of diabetes diagnosis and classification criteria, 172 cases of male and female 91 cases, age 22 to 83 years (mean 52.4 + -12.9 years) carried out all the objects were not hypoglycemic and lipid lowering treatment. except for long-term alcohol consumption, viral hepatitis, drug-induced hepatitis and other liver diseases.
1.2 Methods The subjects hospitalized medical history, including the availability of glucose, lipid treatment, hypertension (HT), alcohol and other history of hepatitis. Systolic blood pressure (SBP) and diastolic blood pressure (DBP), waist circumference ( W). hospital the next day fasting blood test fasting plasma glucose (FPG), liver function, serum uric acid (UA) and total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL C) and low density lipoprotein cholesterol (LDL C), glycosylated hemoglobin (HbA1c), fasting insulin (FINS), both quantitative analysis using automatic biochemical analyzer (BECKMAN COULTER LX20). NAFLD to determine B-mode ultrasound examination with color 1. insulin resistance (IR ) using the following formula
您可能关注的文档
- New Product Marketing- the core product-marketing resources matching.doc
- New Product Marketing.doc
- New philosophy of marketing.doc
- New product development strategies followed in 7 major.doc
- New product market testing before the need for.doc
- New product sales- a practical summary of.doc
- New product success after the three-step targeting.doc
- New Product Tasting nine-step marketing rules.doc
- New product marketing concept chapter- Product Core.doc
- New products enter the market 90 days - the stock market Langjiu Guangxi 2001 New Record.doc
- PDM软件:Siemens Teamcenter二次开发_(17).Teamcenter最佳实践与案例分析.docx
- SCADA软件:GE Proficy二次开发_(4).Proficy开发环境搭建.docx
- 智能电表软件:Landis+Gyr智能电表二次开发_(13).系统集成与测试.docx
- 智能电表软件:Elster智能电表二次开发_(8).Elster智能电表二次开发环境搭建.docx
- PDM软件:Siemens Teamcenter二次开发_(11).TeamcenterAPI与编程基础.docx
- SCADA软件:GE Proficy二次开发_(7).报警与事件管理.docx
- 智能电表软件:Echelon智能电表二次开发_(11).智能电表行业标准与法规.docx
- 智能电表软件:Itron智能电表二次开发_(6).用户界面定制与开发.docx
- 智能电表软件:Elster智能电表二次开发_(9).Elster智能电表二次开发工具使用.docx
- PDM软件:PTC Windchill二次开发_(21).Windchill最佳实践案例分析.docx
文档评论(0)